SG10201500976XA - Treatment or prevention of infection - Google Patents

Treatment or prevention of infection

Info

Publication number
SG10201500976XA
SG10201500976XA SG10201500976XA SG10201500976XA SG10201500976XA SG 10201500976X A SG10201500976X A SG 10201500976XA SG 10201500976X A SG10201500976X A SG 10201500976XA SG 10201500976X A SG10201500976X A SG 10201500976XA SG 10201500976X A SG10201500976X A SG 10201500976XA
Authority
SG
Singapore
Prior art keywords
infection
prevention
treatment
Prior art date
Application number
SG10201500976XA
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Oral Health Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010900846A external-priority patent/AU2010900846A0/en
Application filed by Oral Health Australia Pty Ltd filed Critical Oral Health Australia Pty Ltd
Publication of SG10201500976XA publication Critical patent/SG10201500976XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0208Specific bacteria not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10201500976XA 2010-02-26 2011-02-25 Treatment or prevention of infection SG10201500976XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2010900846A AU2010900846A0 (en) 2010-02-26 Treatment or prevention of infection

Publications (1)

Publication Number Publication Date
SG10201500976XA true SG10201500976XA (en) 2015-04-29

Family

ID=44506081

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201500976XA SG10201500976XA (en) 2010-02-26 2011-02-25 Treatment or prevention of infection
SG2012061099A SG183376A1 (en) 2010-02-26 2011-02-25 Treatment or prevention of infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012061099A SG183376A1 (en) 2010-02-26 2011-02-25 Treatment or prevention of infection

Country Status (17)

Country Link
US (1) US9125853B2 (ru)
EP (2) EP3260135A1 (ru)
JP (1) JP5977677B2 (ru)
KR (2) KR20130036185A (ru)
CN (2) CN102883744A (ru)
AU (1) AU2011220335B2 (ru)
BR (1) BR112012021383A2 (ru)
CA (1) CA2790219C (ru)
HK (1) HK1248535A1 (ru)
MX (1) MX342832B (ru)
MY (1) MY162557A (ru)
NZ (1) NZ601890A (ru)
RU (1) RU2617399C2 (ru)
SG (2) SG10201500976XA (ru)
TW (1) TWI583392B (ru)
WO (1) WO2011103633A1 (ru)
ZA (1) ZA201206204B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
NZ598834A (en) 2008-08-29 2013-06-28 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
EP2443143A4 (en) * 2009-06-19 2013-09-11 Oral Health Australia Pty Ltd CASEIN-DERIVED PROTEASE-INHIBITING FIBERS
WO2016061264A1 (en) * 2014-10-14 2016-04-21 The Forsyth Institute Conjugates for delivery to mitochondria
KR101587113B1 (ko) * 2014-10-29 2016-01-20 경북대학교 산학협력단 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지
WO2017102927A1 (en) * 2015-12-15 2017-06-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccination against diabetes, obesity and complications thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210035A (en) 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4735801A (en) 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
WO1993014779A1 (en) 1992-01-30 1993-08-05 Corvas International, Inc. Trypsin inhibitors
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AUPP893999A0 (en) 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
GB0114185D0 (en) 2001-06-12 2001-08-01 Protherics Molecular Design Lt Compounds
GB2370838A (en) 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
CA2490129A1 (en) 2002-06-26 2004-01-08 Entremed, Inc. Compositions and methods comprising protein activated receptor antagonists
JPWO2004083425A1 (ja) 2003-03-17 2006-06-22 麒麟麦酒株式会社 歯周病治療剤
WO2005016249A2 (en) * 2003-07-11 2005-02-24 Pharmacia Corporation Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ace inhibitor for the treatment of central nervous system damage
JP2007529195A (ja) * 2003-08-15 2007-10-25 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インク. 歯周病の診断,治療,およびモニタリングのためのPorphyromonasgingivalis毒性ポリヌクレオチドの同定
GB0411150D0 (en) * 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
EP1778652A2 (en) 2004-08-20 2007-05-02 EntreMed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
WO2006032104A1 (en) * 2004-09-23 2006-03-30 The University Of Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
US7888482B2 (en) 2006-02-10 2011-02-15 Amgen Inc. Antibodies that bind PAR-2
US20100092471A1 (en) 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
ES2714008T3 (es) 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
RU2366378C1 (ru) * 2008-04-07 2009-09-10 Сергей Владимирович Сирак Способ костной пластики при непосредственной дентальной имплантации
CN102712693A (zh) * 2009-08-02 2012-10-03 圣诺菲·帕斯图尔有限公司 牙龈卟啉单胞菌多肽

Also Published As

Publication number Publication date
SG183376A1 (en) 2012-09-27
BR112012021383A2 (pt) 2017-07-25
KR20170109685A (ko) 2017-09-29
MX342832B (es) 2016-10-14
JP5977677B2 (ja) 2016-08-24
RU2617399C2 (ru) 2017-04-24
US9125853B2 (en) 2015-09-08
CA2790219A1 (en) 2011-09-01
AU2011220335A1 (en) 2012-09-06
CA2790219C (en) 2020-06-30
EP2538970A4 (en) 2013-12-18
WO2011103633A1 (en) 2011-09-01
CN104689308A (zh) 2015-06-10
AU2011220335B2 (en) 2015-04-02
US20130129768A1 (en) 2013-05-23
EP3260135A1 (en) 2017-12-27
CN102883744A (zh) 2013-01-16
NZ601890A (en) 2015-01-30
CN104689308B (zh) 2020-10-20
RU2012136724A (ru) 2014-04-10
ZA201206204B (en) 2013-05-29
KR20130036185A (ko) 2013-04-11
EP2538970A1 (en) 2013-01-02
HK1248535A1 (zh) 2018-10-19
TW201138813A (en) 2011-11-16
MX2012009730A (es) 2013-02-07
JP2013520448A (ja) 2013-06-06
TWI583392B (zh) 2017-05-21
MY162557A (en) 2017-06-15

Similar Documents

Publication Publication Date Title
ZA201304280B (en) Treatment of jak2-mediated conditions
IL220876A0 (en) Treatment of cardiac conditions
HK1248535A1 (zh) 感染的治療或預防
ZA201301601B (en) Treatment of diseases
SG10201508495VA (en) Combination treatment of cancer
EP2613786A4 (en) TREATMENT OF DISEASES
EP2651439A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HUMAN ADENOVIRUS 36 INFECTION
GB0915515D0 (en) Treatment of vasculoproliferative conditions
GB201217097D0 (en) Treatment of bacterial infection
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
IL256026B (en) Treatment methods
PL2534150T3 (pl) Sposoby leczenia infekcji wirusowej
PL2545158T3 (pl) Traktowanie roślin przeciwko zakażeniu lęgniowcami
EP2549867A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF INJURIES
EP2522360A4 (en) VACCINE FOR TAUTOPATHY TREATMENT
EP2794885A4 (en) PREVENTION AND TREATMENT OF MYCOBACTERIUM INFECTION
EP2712317A4 (en) PREVENTION OF INFECTIONS
ZA201207496B (en) Treatment of chicory
EP2403507A4 (en) TREATMENT OF INFECTIONS
ZA201103007B (en) Treatment of tantalium-and/or niobium-containing compounds
ZA201207497B (en) Treatment of chicory
HK1174256A1 (en) Treatment and prevention of hiv infection hiv
AU2010900846A0 (en) Treatment or prevention of infection
HK1198742A1 (en) Prevention and treatment of hiv infection hiv
AU2009900969A0 (en) Treatment of infection